Company Data
Passage Bio Inc.
Ticker
PASG
Current Price
$0.5315 -3.36%
Market Cap
$32.8M
Price Target
Refer to Report
Volume
43.7K
52wk Range
$0.451 - $1.79
Overview
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.